Effectiveness of Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) Using the Longer Duration Protocol in Lowering IOP in Patients with Glaucoma
Pakistan Journal of Ophthalmology · 31.03.2026 · 42 (2)
DOI: 10.36351/pjo.v42i2.2205 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Pakistan Journal of Ophthalmology, online erschienen am 31.03.2026. Verfasst von Imran Ghayoor und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Purpose
To evaluate the short-term effectiveness and associated predictors of intraocular pressure (IOP) reduction following micropulse transscleral cyclophotocoagulation (MP-TSCPC) in patients with glaucoma. Study Design: Prospective observational study. Place and Duration of Study: Conducted at Liaquat National Hospital, Karachi, from July 12, 2024, to January 13, 2025.
Methods
Patients with uncontrolled glaucoma undergoing MP-TSCPC were enrolled. IOP was measured at baseline, 1 month, and 3 months post-procedure. Treatment effectiveness was defined as a ≥20% reduction in IOP without need for further surgical intervention. Friedman test and Wilcoxon signed-rank tests assessed changes over time. Categorical associations were examined using chi-square test, and predictors of effectiveness were analyzed via univariate and multivariable logistic regression.
Results
A total of 97 eyes were analyzed. Median baseline IOP was 20 mmHg (IQR: 17–31), which significantly reduced to 16 mmHg (IQR: 14–22) at 1 month and 14 mmHg (IQR: 11–17) at 3 months (p < 0.001). Treatment was effective in 76 eyes (78.4%). Male gender (p < 0.001), longer glaucoma duration (p = 0.03), and moderate severity (p = 0.038) were significantly associated with effectiveness. In multivariable regression, only male gender remained an independent predictor (aOR = 10.59, 95% CI: 2.11–53.21, p = 0.004).
Conclusion
MP-TSCPC significantly lowered IOP at 1 and 3 months. Approximately four-fifths of patients achieved effective outcomes, with male gender being a strong predictor of success. The procedure appears safe and beneficial for short-term glaucoma control.
Zitieren
APA
Ghayoor, I., Ather, R., Shakir, M., Khan, N., & Azmi, S. (2026). Effectiveness of Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) Using the Longer Duration Protocol in Lowering IOP in Patients with Glaucoma. Pakistan Journal of Ophthalmology, 42(2). https://doi.org/10.36351/pjo.v42i2.2205
Vancouver
Ghayoor I, Ather R, Shakir M, Khan N, Azmi S. Effectiveness of Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) Using the Longer Duration Protocol in Lowering IOP in Patients with Glaucoma. Pakistan Journal of Ophthalmology. 2026;42(2). doi:10.36351/pjo.v42i2.2205
BibTeX
@article{Ghayoor2026,
author = {Ghayoor, Imran and Ather, Rida and Shakir, Munira and Khan, Nazish and Azmi, Salman},
title = {Effectiveness of Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) Using the Longer Duration Protocol in Lowering IOP in Patients with Glaucoma},
journal = {Pakistan Journal of Ophthalmology},
year = {2026},
volume = {42},
number = {2},
doi = {10.36351/pjo.v42i2.2205}
}
EUVIMED